News & Trends - Pharmaceuticals
Medicines Australia CEO voices policy and advocacy focus for 2024
Pharma News: In this Health Industry Hub interview, Liz de Somer, CEO of Medicines Australia, acknowledged the top highlights that led to meaningful change in 2023, and voiced the key policy agenda for the new year.
The delayed government response to The New Frontier report was addressed, with a focus on organisations expressing disappointment due to the response mainly supporting recommendations already in progress.
The Health Technology Assessment (HTA) Review took centre stage, with concerns raised about transparency and progress against deadlines. The delayed consultation 2 opens for submissions in the week of 22 January with online and in-person workshops planned to take place throughout February 2024.
Looking ahead, the interview touched upon the potential impact of an early federal election on the HTA Review’s success. Ms de Somer shared insights into Medicines Australia’s strategic objectives and policy focus areas for 2024, emphasising the goals aimed at delivering significant impacts for both patients and the pharmaceutical industry.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
Leadership & Management
New study challenges trend-driven leadership frameworks
The secret to effective leadership may lie in its simplicity. New research highlights the importance of strong leader-follower relationships over […]
MoreNews & Trends - Pharmaceuticals
Complex policy problem: How to tackle Australia’s persistent medicine shortages
The debate over medicine shortages has erupted again, as the Australian Medical Association (AMA) and the Pharmacy Guild of Australia […]
MoreNews & Trends - MedTech & Diagnostics
Overhaul of funding for CIED technical services expected to take up to 18 months
The Department of Health (DoH) has unveiled stakeholder views regarding the current approach to cardiac implantable electronic devices (CIED) and […]
MoreMedical and Science
Demand surges for scientist role in policy-making amid calls for more transparency
Two-thirds of Australians believe scientists should actively advocate for specific policies, with over 60% urging greater scientist involvement in policy-making. […]
More